Literature DB >> 20671130

I don't know how to treat amyloidosis.

Morie A Gertz1.   

Abstract

Entities:  

Year:  2010        PMID： 20671130     DOI： 10.1182/blood-2010-04-279901

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  3 in total

1.  Bortezomib-dexamethasone versus high-dose melphalan for Japanese patients with systemic light-chain (AL) amyloidosis: a retrospective single-center study.

Authors:  Nagaaki Katoh; Akihiro Ueno; Takuhiro Yoshida; Ko-Ichi Tazawa; Yasuhiro Shimojima; Takahisa Gono; Yoshiki Sekijima; Masayuki Matsuda; Shu-Ichi Ikeda
Journal:  Int J Hematol       Date:  2016-11-10       Impact factor: 2.490

2.  Auto-SCT improves survival in systemic light chain amyloidosis: a retrospective analysis with 14-year follow-up.

Authors:  S Parmar; P Kongtim; R Champlin; Y Dinh; Y Elgharably; M Wang; Q Bashir; J J Shah; N Shah; U Popat; S A Giralt; R Z Orlowski; M H Qazilbash
Journal:  Bone Marrow Transplant       Date:  2014-06-02       Impact factor: 5.483

Review 3.  Fifty years of melphalan use in hematopoietic stem cell transplantation.

Authors:  Ulas D Bayraktar; Qaiser Bashir; Muzaffar Qazilbash; Richard E Champlin; Stefan O Ciurea
Journal:  Biol Blood Marrow Transplant       Date:  2012-08-24       Impact factor: 5.742
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.